Invest now
Aurobindo Pharma Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,570.90 +10.35 (0.66%)Updated : 21 Jul 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 58,502.15 | 49,784.97 | 45,071.51 | 39,889.99 |
| Cash Equivalents | 9,870.29 | 2,919.57 | 2,110.91 | 2,729.66 |
| Other Liabilities Total | 1,178.64 | 351.57 | 277.59 | 214.26 |
| Long Term Debt | 802.75 | 1,561.65 | 2,134.90 | 618.96 |
| Common Stock Total | 58.08 | 58.08 | 58.59 | 58.59 |
| Other Current Assets Total | 2,803.41 | 43.13 | 445.24 | 114.60 |
| Total Assets | 58,502.15 | 49,784.97 | 45,071.51 | 39,889.99 |
| Current Portof LT Debt/ Capital Leases | 6,977.15 | 1,152.29 | 182.08 | 181.00 |
| Total Equity | 37,890.97 | 32,653.32 | 29,842.80 | 26,839.85 |
| Long Term Investments | 853.78 | 251.70 | 321.65 | 391.74 |
| Retained Earnings( Accumulated Deficit) | 37,832.89 | 30,681.61 | 27,848.33 | 24,957.32 |
| Total Common Shares Outstanding | 58.08 | 58.08 | 58.59 | 58.59 |
| Tangible Book Valueper Share Common Eq | 561.46 | 489.23 | 439.74 | 391.13 |
| Goodwill Net | 800.15 | 618.02 | 595.15 | 596.07 |
| Total Liabilities | 20,611.18 | 17,131.65 | 15,228.71 | 13,050.14 |
| Total Debt | 8,072.84 | 8,262.87 | 6,647.63 | 5,286.21 |
| Short Term Investments | 848.19 | 2,632.33 | 2,932.88 | 1,836.42 |
| Cashand Short Term Investments | 10,718.48 | 8,201.28 | 6,326.36 | 6,232.71 |
| Total Receivables Net | 7,133.92 | 8,374.33 | 7,625.80 | 6,687.13 |
| Deferred Income Tax | 306.00 | 303.27 | 356.56 | 389.61 |
| Accounts Receivable- Trade Net | 7,094.37 | 5,873.95 | 5,036.43 | 4,653.50 |
| Property/ Plant/ Equipment Total- Net | 17,338.76 | 15,455.43 | 14,284.90 | 12,491.78 |
| Minority Interest | -8.16 | -6.39 | 8.00 | 12.00 |
| Total Current Liabilities | 18,039.01 | 14,682.34 | 12,199.13 | 11,493.78 |
| Total Inventory | 12,052.94 | 10,543.72 | 9,808.23 | 8,511.23 |
| Accounts Payable | 5,567.27 | 4,188.85 | 4,454.16 | 3,871.31 |
| Other Currentliabilities Total | 5,494.59 | 3,785.22 | 3,138.51 | 3,069.12 |
| Total Long Term Debt | 1,095.69 | 1,800.86 | 2,387.43 | 940.49 |
| Intangibles Net | 4,481.23 | 3,620.70 | 3,481.46 | 3,325.85 |
| Other Long Term Assets Total | 1,859.48 | 1,468.33 | 1,366.35 | 832.39 |
| Note Receivable- Long Term | 460.00 | 1,208.33 | 816.37 | 706.49 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 32,708.75 | 27,162.46 | 24,205.63 | 21,545.67 |
| Capital Lease Obligations | 292.94 | 239.21 | 252.53 | 321.53 |
| Accumulated Depreciation Total | - | -6,538.47 | -6,372.69 | -5,559.35 |
| Accrued Expenses | - | 246.26 | 346.26 | 207.63 |
| Other Equity Total | - | 1,838.52 | 1,517.99 | 1,406.05 |
| Additional Paid- In Capital | - | 75.11 | 417.89 | 417.89 |
| Cash | - | 2,649.38 | 1,282.57 | 1,666.63 |
| Property/ Plant/ Equipment Total- Gross | - | 18,727.90 | 17,918.20 | 13,554.73 |
| Notes Payable/ Short Term Debt | - | 5,309.72 | 4,078.12 | 4,164.72 |
*All figures in crores except per share values
Aurobindo Pharma Quick Links
Aurobindo Pharma Dividend Aurobindo Pharma Bonus Aurobindo Pharma News Aurobindo Pharma AGM Aurobindo Pharma Rights Aurobindo Pharma Splits Aurobindo Pharma Board Meetings Aurobindo Pharma Key Metrics Aurobindo Pharma Shareholdings Aurobindo Pharma Profit Loss Aurobindo Pharma Cashflow Aurobindo Pharma Q1 Results Aurobindo Pharma Q2 Results Aurobindo Pharma Q3 Results Aurobindo Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,570.50+59.15(3.91%)
389.85+12.70(3.37%)
2,268.25+66.45(3.02%)
1,933.10-16.90 (-0.87%)
2,840.00-19.55 (-0.68%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.